期刊文献+

高密度脂蛋白胆固醇与冠心病及其危险因素的回顾性分析 被引量:8

Retrospective analysis of the association between HDL-C and coronary heart disease and risk factors of coronary heart disease
下载PDF
导出
摘要 目的:探讨高密度脂蛋白胆固醇(HDL-C)与冠心病、冠心病危险因素的关系。方法:将931份心脏科住院病例按HDL-C水平分为3组,小于1.04 mmol/L为低水平组,1.04~1.54 mmol/L为适当水平组,大于等于1.55 mmol/L为高水平组,对3组资料进行回顾性分析。结果:甘油三酯(TG)、动脉粥样硬化指数、尿酸(UA)、血糖、急性心肌梗死和2型糖尿病患病率高水平组和(或)适当水平组明显低于低水平组(P<0.05),高水平组较适当水平组2型糖尿病和急性心肌梗死患病率、随机血糖、低密度脂蛋白(LDL)无显著差异(P>0.05)。3组病人的住院天数、高血压、心律失常、冠心病患病率无明显差别(P>0.05)。高水平组总胆固醇(TC),收缩压最高(P<0.05)。结论:虽然高水平、适当水平组较低水平组心血管保护作用明显,但高水平组较适当水平组心血管保护作用不显著。高密度脂蛋白胆固醇的质量比数量重要。 Objective: To study the relationships between HDL-C and coronary heart disease(CHD) and CHD risk factors. Methods: All data were taken from 931 patients admitted to the department of cardiology. The patients were divided into 3 groups according to the level of HDL-C, which were designated low (〈1.04 mmol/L), normal (1.04- 1.54 mmol/L) or high(〉1.54 mmol/L). The demographics and CHD risk factors?for each group were analyzed. Results: The level of TG, LDL-C/HDL-C, uric acid (UA), blood sugar, rates of type 2 diabetes and acute myocardial infarction(AMI) in the high and/or normal groups were lower than those of the low HDL-C group (P 〈0.05). Compared with those of normal HDL-C, the high HDL group had no significantly decrease in type 2 diabetes and AMI, random blood sugar , LDL (P〉0.05).Tbe length of hospital stay, rates of CHD, hypertension and arhythemia were not statistical different among the three groups (P〉0.05), while the high HDL-C group had on average the greatest level of TC, systolic blood pressure (SBP). Conclusion: Although compared with low HDL-C group, normal and high HDL-C group provide obvious protection against CHD, elevated HDL-C above normal levels do not provide obvious protection .HDL-C' quality is more important than its quantity.
出处 《天津医科大学学报》 2009年第2期259-262,共4页 Journal of Tianjin Medical University
关键词 高密度脂蛋白胆固醇 冠心病 危险因素 炎性高密度脂蛋白 HDL-C Coronary heart disease Risk factors Infl- high density lipoprotein
  • 相关文献

参考文献10

  • 1Gotto AM Jr,Brinton EA.Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary disease:a working group report and update[J].J Am Coll Cardiol,2004,43(5):717.
  • 2高密度脂蛋白胆固醇增高并不是心脏保护的良好指标[J].中华高血压杂志,2007,15(11):966-966. 被引量:1
  • 3黄贤圣,赵水平.炎性高密度脂蛋白的结构和功能改变及其临床意义[J].中华心血管病杂志,2008,36(8):676-678. 被引量:4
  • 4van der Westhuyzen DR,de Beer FC,Webb NR.HDL cholesteroltransport during inflammation[J].Curr Opin Lipidol,2007,18(2):147.
  • 5Zheng L,Nukuna B,Brennan ML,et al.Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease[J].J Clin Incest,2004,114(4):529.
  • 6张春妮,万建美.高密度脂蛋白氧化修饰与动脉硬化[J].中国病理生理杂志,2003,19(5):708-711. 被引量:1
  • 7Ansell BJ,Navab M,Hama S,et al.Inflammatory/anti inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment[J].Circulation,2003,108(22):2751.
  • 8Uzunlulu M,Oguz A,Tigen K.High-density lipoprotein cholesterol in coronary artery disease patients:is it as low as expected[J].Anadolu Kardiyol Derg,2005,5(4):268.
  • 9DeFaria Yeh D,Freeman MV,Meiqs JB,et al.Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol[J].Am J Cardiol,2007,99(1):1.
  • 10Jov T,Heqele RA.Is raising HDL a futile strategy for atheroprotection[J].Nat Rey Drug Discov,2008,7(2):143.

二级参考文献23

  • 1Duffy D, Rader DJ. Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport. Circulation, 2006, 113 : 1140-1150.
  • 2Wolfrum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efllux to HDL and protects against atherosclerosis. Nat Med, 2005, 11:418-422.
  • 3Lamant M, Smih F, Harmancey R, et al. Apo O, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart. J Biol Chem, 2006, 281:36289-36302.
  • 4Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res. 2004, 95:764-772.
  • 5Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis : the role of oxidized phospholipids and HDL. J Lipid Re.s, 2004, 45:993-1007.
  • 6Van Lenten B J, Wagner AC, Nayak DP, et al. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation, 2001,103: 2283-2288.
  • 7AnseU BJ, Navab M, Hama S, et al. Inflammatory/ antiinflananatory properties of high-density lipeprotein distinguish patients from control subjects better than high-density lipeprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation, 2003, 108:2751-2756.
  • 8Zheng L, Nukuna B, Brennan ML, et al. Apolipoprctein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest, 2004, 114:529-541.
  • 9Gowri MS, Van der Westhuyzen DR, Bridges SB, et al. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler Thromb Vasc Biol, 1999, 19: 2226-2233.
  • 10Navab M, Berliner JA,Subbanagounder G, et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol, 2001, 21 : 481- 488.

共引文献3

同被引文献72

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部